Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32
Recall Number: D-0820-2021
Firm: Glenmark Pharmaceuticals Inc., USA
Classification: Class II
Status: Terminated
Report Date: 20210929
Initiation Date: 20210827
Termination Date: 20231004
Reason for Recall
Lack of Assurance of Sterility
Product Description
Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32